Search Results - Skanji, D

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial

    Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SU... by Tabernero, J., Taieb, J., Fakih, M., Prager, G.W., Van Cutsem, E., Ciardiello, F., Mayer, R.J., Amellal, N., Skanji, D., Calleja, E., Yoshino, T.

    Published in ESMO open
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    PIN3 Burden of Cytomegalovirus Disease in Immunosuppressed Persons Following Transplantation in France

    PIN3 Burden of Cytomegalovirus Disease in Immunosuppressed Persons Following Transplantation in France by Goryakin, Y, Ferchichi, S, Skanji, D, Odeyemi, I.I, Hakimi, Z, Aballea, S

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Impact of KRAS G12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial

    Impact of KRAS G12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III S... by Tabernero, J, Taieb, J, Fakih, M, Prager, G W, Van Cutsem, E, Ciardiello, F, Mayer, R J, Amellal, N, Skanji, D, Calleja, E, Yoshino, T

    Published in ESMO open
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: